Cargando…

Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

Detalles Bibliográficos
Autores principales:	Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Moreno-Aspitia, Alvaro, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415798/ https://www.ncbi.nlm.nih.gov/pubmed/25928305 http://dx.doi.org/10.1371/journal.pone.0127133

Ejemplares similares

Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors
por: Necela, Brian M., et al.
Publicado: (2015)

Gene Expression, Single Nucleotide Variant and Fusion Transcript Discovery in Archival Material from Breast Tumors
por: Norton, Nadine, et al.
Publicado: (2013)

Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors
por: Norton, Nadine, et al.
Publicado: (2016)

The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
por: Necela, Brian M., et al.
Publicado: (2017)

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease
por: O’Shannessy, Daniel J, et al.
Publicado: (2012)

Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis
por: Borges, Sahra, et al.
Publicado: (2013)

Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor as Potential Serum Markers of Chronic Kidney Disease
por: Somers, Elizabeth B, et al.
Publicado: (2014)

Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate
por: Tang, Thao, et al.
Publicado: (2022)

Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2(+) breast cancer samples
por: Vasmatzis, George, et al.
Publicado: (2018)

An Integrated Model of the Transcriptome of HER2-Positive Breast Cancer
por: Kalari, Krishna R., et al.
Publicado: (2013)

Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations
por: Kalari, Krishna R., et al.
Publicado: (2012)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
por: Huang, Ming-ju, et al.
Publicado: (2018)

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
por: Nicolaides, Nicholas C., et al.
Publicado: (2014)

The Parsortix™ Cell Separation System—A versatile liquid biopsy platform
por: Miller, M. Craig, et al.
Publicado: (2018)

Development of (89)Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications
por: Lange, Sara E.S., et al.
Publicado: (2016)

Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha
por: O’Shannessy, Daniel J., et al.
Publicado: (2016)

Feasibility of an Intensive, Disorder-Specific, Group-Based Cognitive Behavioural Therapy Intervention for Adolescents with Social Anxiety Disorder
por: O’Shannessy, Dustin M., et al.
Publicado: (2021)

Differentially expressed genes in embryonic cardiac tissues of mice lacking Folr1 gene activity
por: Zhu, Huiping, et al.
Publicado: (2007)

Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy
por: Serie, Daniel J., et al.
Publicado: (2017)

Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins
por: O'Shannessy, Daniel J., et al.
Publicado: (2014)

Reinforcing one-carbon metabolism via folic acid/Folr1 promotes β-cell differentiation
por: Karampelias, Christos, et al.
Publicado: (2021)

Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure
por: Norton, Nadine, et al.
Publicado: (2020)

A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines
por: Asmann, Yan W., et al.
Publicado: (2011)

Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers
por: O’Shannessy, Daniel J, et al.
Publicado: (2015)

Pathophysiological Roles of PPARγ in Gastrointestinal Epithelial Cells
por: Necela, Brian M., et al.
Publicado: (2008)

Differential Expression of MicroRNAs in Tumors from Chronically Inflamed or Genetic (APC(Min/+)) Models of Colon Cancer
por: Necela, Brian M., et al.
Publicado: (2011)

Tandem CAR-T cells targeting FOLR1 and MSLN enhance the antitumor effects in ovarian cancer
por: Liang, Zhen, et al.
Publicado: (2021)

CIC de novo loss of function variants contribute to cerebral folate deficiency by downregulating FOLR1 expression
por: Cao, Xuanye, et al.
Publicado: (2021)

Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer
por: Strizzi, Luigi, et al.
Publicado: (2012)

Implications of a Supernumerary Nipple Breast Cancer in a BReast CAncer Sequence Variation Carrier: A Case Report
por: Sperduto, Will, et al.
Publicado: (2023)

Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies
por: O'Shannessy, Daniel J., et al.
Publicado: (2016)

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer
por: Barrett, Michael T., et al.
Publicado: (2015)

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
por: Köbel, M, et al.
Publicado: (2014)

Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian Cancer
por: O’Shannessy, Daniel J., et al.
Publicado: (2013)

Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer
por: Kim, Minsung, et al.
Publicado: (2018)

FOLR1-induced folate deficiency reduces viral replication via modulating APOBEC3 family expression
por: Wu, Jing, et al.
Publicado: (2023)

The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data
por: Tang, Xiaojia, et al.
Publicado: (2014)

Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4
por: O’Shannessy, Daniel J, et al.
Publicado: (2013)

Folic acid modifies the shape of epithelial cells during morphogenesis via a Folr1 and MLCK dependent mechanism
por: Martin, Jessica B., et al.
Publicado: (2019)

Activity, Participation, and Goal Awareness After Acquired Brain Injury: A Prospective Observational Study of Inpatient Rehabilitation
por: Adey-Wakeling, Zoe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mn8gr40eaollmf4lbadaerd18n